Identification of super-enhancer-based biomarkers for predicting survival and immunotherapy efficacy in colorectal cancer
Journal of Cancer · 2026-01-01 · 17 (2) · 338-358
DOI: 10.7150/jca.119265 ↗At a glance
Journal article in Journal of Cancer, published on 2026-01-01. Written by Yanan Yu and 8 co-authors. Institution: Department of Oncology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, W…. Cited 1 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Immune checkpoint inhibitors are effective treatments for many tumors. However, existing biomarkers can benefit only a small selection of colorectal cancer patients. Super-enhancers are associated with various tumor characteristics. We wondered whether super-enhancer-related genes could be novel biomarkers for immunotherapy. We screened super-enhancer-related genes that were highly correlated with immune infiltration through weighted gene co-expression network analysis on the basis of chromatin immunoprecipitation sequencing data. A prognostic risk signature was established using least absolute shrinkage and selection operator and cox regression models. By analyzing the correlations between the expression of model genes and the immunophenotypic and microsatellite instability scores, we determined that PLAU and GSDMC expression had high predictive value for immunotherapy efficacy. Moreover, we predicted the sensitivity of the PLAU and GSDMC proteins to drugs by virtual docking. Finally, we validated the effect of the super-enhancer activity on PLAU and GSDMC expression. Overall, our study identified super-enhancer-based biomarkers for predicting survival and immunotherapy efficacy in colorectal cancer.
Subjects
Author keywords
Authors and institutions
- Department of Oncology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang 261053, Shandong, China.
- Department of Medical Oncology, Rizhao central hospital, Rizhao 276801, Shandong, China.
- Department of Radiotherapy, Affiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, Weifang 261053, Shandong, China.
Cite
APA
Yu, Y., Zhang, X., Ma, X., Ren, J., Zhang, J., Zhu, L., Chen, Y., Lu, Z., & Li, J. (2026). Identification of super-enhancer-based biomarkers for predicting survival and immunotherapy efficacy in colorectal cancer. Journal of Cancer, 17(2), 338-358. https://doi.org/10.7150/jca.119265
Vancouver
Yu Y, Zhang X, Ma X, Ren J, Zhang J, Zhu L, et al. Identification of super-enhancer-based biomarkers for predicting survival and immunotherapy efficacy in colorectal cancer. Journal of Cancer. 2026;17(2):338-358. doi:10.7150/jca.119265
BibTeX
@article{Yu2026,
author = {Yu, Yanan and Zhang, Xiuxiu and Ma, Xiaolin and Ren, Jiao and Zhang, Jinglei and Zhu, Luoyu and Chen, Yanfang and Lu, Zhong and Li, Jiaqiu},
title = {Identification of super-enhancer-based biomarkers for predicting survival and immunotherapy efficacy in colorectal cancer},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {2},
pages = {338--358},
doi = {10.7150/jca.119265}
}
EUVIMED